---
schema_version: "secwatch.filing_event.v1"
accession: "0001932393-25-000004"
form_type: "8-K"
ticker: "GEHC"
cik: "0001932393"
company_name: "GE HealthCare Technologies Inc."
filed_at: "2025-02-13T23:59:59+00:00"
generated_at: "2026-05-26T22:26:32.513344+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# GE HealthCare reports Q4 EPS $1.57, adjusted EPS $1.45; guides FY2025 adjusted EPS $4.61-$4.75

## Summary
- Q4 revenue $5.3B, up 2% organic; net income $720M (13.5% margin) vs $403M (7.7%).
- Diluted EPS $1.57 vs $0.88; Adjusted EPS $1.45 vs $1.18; Adjusted EBIT margin 18.7% vs 16.1%.
- FY2024 revenue $19.7B (+1% organic); net income $2.0B; diluted EPS $4.34; Adjusted EPS $4.49.
- FY2025 guidance: organic revenue growth 2-3%; adjusted EBIT margin 16.7-16.8%; adjusted EPS $4.61-$4.75.
- Segment highlights: Advanced Visualization Solutions (+4% organic) and Pharmaceutical Diagnostics (+9%) grew; China weakness noted.

## SEC filing metadata
- accession: 0001932393-25-000004
- form_type: 8-K
- ticker: GEHC
- cik: 0001932393
- company_name: GE HealthCare Technologies Inc.
- filed_at: 2025-02-13T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1932393/000193239325000004/0001932393-25-000004-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1932393/000193239325000004/gehc-20250213.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001932393-25-000004
- JSON: https://secwatch.observer/filing/0001932393-25-000004.json
- Plain text: https://secwatch.observer/filing/0001932393-25-000004.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.